{
    "Trade/Device Name(s)": [
        "AG-608 Blood Glucose Monitoring System",
        "AG-610 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Andon Medical Co., Ltd.",
    "510(k) Number": "K093262",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073030"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "June 25, 2010",
    "Summary Letter Received Date": "June 25, 2010",
    "Submission Date": "September 30, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AG-608 Blood Glucose Meter",
        "AG-610 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technology",
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Lancet",
        "Lancing device",
        "Control solution"
    ],
    "Document Summary": "FDA 510(k) summary for Andon Medical AG-608 and AG-610 Blood Glucose Monitoring System for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the finger for home and clinical monitoring of diabetes mellitus; not for neonatal use or for diagnosis or screening of diabetes mellitus",
    "fda_folder": "Clinical Chemistry"
}